Torrent Pharmaceuticals Limited (TORNTPHARM.NS)
INR 3458.4
(2.26%)
INR 3458.4
(2.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 106.05 Billion | 94.64 Billion | 84.18 Billion | 78.86 Billion | 77.8 Billion | 74.61 Billion |
| Cost of Revenue | 59.29 Billion | 27.35 Billion | 25.37 Billion | 22.35 Billion | 22.52 Billion | 23.21 Billion |
| Gross Profit | 46.75 Billion | 67.29 Billion | 58.81 Billion | 56.5 Billion | 55.27 Billion | 51.4 Billion |
| Operating Expenses | 21.42 Billion | 45.94 Billion | 41.11 Billion | 38.22 Billion | 40.08 Billion | 37.71 Billion |
| Selling, General and Administrative Expenses | 16.15 Billion | 16.4 Billion | 14.39 Billion | 13.22 Billion | 14.13 Billion | 13.48 Billion |
| Research and Development Expenses | 5.27 Billion | 312.7 Million | 386.5 Million | 251.8 Million | 925.1 Million | 5.38 Billion |
| Other Expenses | - | 450 Million | 97.3 Million | 40.3 Million | 14 Million | 24.6 Million |
| Cost and Expenses | 80.71 Billion | 73.29 Billion | 66.49 Billion | 60.57 Billion | 62.61 Billion | 60.93 Billion |
| Operating Income | 25.33 Billion | 21.4 Billion | 17.69 Billion | 18.22 Billion | 15.18 Billion | 13.68 Billion |
| Interest Expense | 3.53 Billion | 3.33 Billion | 2.52 Billion | 3.56 Billion | 4.48 Billion | 5.01 Billion |
| Income Tax Expense | 6.95 Billion | 6.02 Billion | 4.48 Billion | 2.74 Billion | 1.61 Billion | 1.25 Billion |
| Earnings before Tax | 23.52 Billion | 18.47 Billion | 12.25 Billion | 15.26 Billion | 11.86 Billion | 5.61 Billion |
| Net Income | 16.56 Billion | 12.45 Billion | 7.77 Billion | 12.51 Billion | 10.24 Billion | 4.36 Billion |
| Earnings Per Share Basic | 48.94 | 36.79 | 22.96 | 36.99 | 30.28 | 12.89 |
| Earnings Per Share Diluted | 48.94 | 36.79 | 22.96 | 36.99 | 30.28 | 12.89 |
| Weighted Average Shares Outstanding | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million |
| Gross Margin | 0.44 | 0.71 | 0.70 | 0.72 | 0.71 | 0.69 |
| EBIT Margin | 0.33 | 0.31 | 0.31 | 0.32 | 0.29 | 0.27 |
| Profit Margin | 0.16 | 0.13 | 0.09 | 0.16 | 0.13 | 0.06 |
| EBITDA | 35 Billion | 28.82 Billion | 21.42 Billion | 25.36 Billion | 22.88 Billion | 16.79 Billion |
| Earnings Before Tax Margin | 0.24 | 0.23 | 0.21 | 0.23 | 0.20 | 0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 28.31 Billion | 28.59 Billion | 107.28 Billion | 27.45 Billion | 26.91 Billion | 26.28 Billion |
| Cost of Revenue | 6.78 Billion | 14.41 Billion | 54.78 Billion | 13.68 Billion | 6.97 Billion | 6.6 Billion |
| Gross Profit | 21.53 Billion | 14.18 Billion | 52.5 Billion | 13.77 Billion | 19.94 Billion | 19.68 Billion |
| Operating Expenses | 14.12 Billion | 7.11 Billion | 26.9 Billion | 6.97 Billion | 13.38 Billion | 13.44 Billion |
| Selling, General and Administrative Expenses | 5.84 Billion | 5.76 Billion | - | 5.58 Billion | 5.43 Billion | 5.4 Billion |
| Research and Development Expenses | 1.45 Billion | 1.35 Billion | - | 1.39 Billion | 1.27 Billion | 1.32 Billion |
| Other Expenses | 14.12 Billion | 240 Million | 580 Million | 310 Million | -330 Million | 260 Million |
| Cost and Expenses | 20.9 Billion | 21.52 Billion | 81.68 Billion | 20.65 Billion | 20.35 Billion | 20.04 Billion |
| Operating Income | 7.41 Billion | 7.07 Billion | 25.6 Billion | 6.8 Billion | 6.23 Billion | 6.5 Billion |
| Interest Expense | 640 Million | 750 Million | 3.54 Billion | 800 Million | 800 Million | 910 Million |
| Income Tax Expense | 2.08 Billion | 1.99 Billion | 6.96 Billion | 1.82 Billion | 1.88 Billion | 1.73 Billion |
| Earnings before Tax | 6.61 Billion | 6.56 Billion | 23.52 Billion | 6.31 Billion | 6.31 Billion | 5.59 Billion |
| Net Income | 4.53 Billion | 4.57 Billion | 16.56 Billion | 4.49 Billion | 4.43 Billion | 3.86 Billion |
| Earnings Per Share Basic | 13.37 | 13.50 | - | 13.27 | 13.09 | 11.41 |
| Earnings Per Share Diluted | 13.37 | 13.50 | - | 13.27 | 13.09 | 11.41 |
| Weighted Average Shares Outstanding | 338.81 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 338.81 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million | 338.44 Million |
| Gross Margin | 0.76 | 0.50 | 0.49 | 0.50 | 0.74 | 0.75 |
| EBIT Margin | 0.33 | 0.32 | - | 0.32 | 0.31 | 0.32 |
| Profit Margin | 0.16 | 0.16 | 0.15 | 0.16 | 0.16 | 0.15 |
| EBITDA | 9.23 Billion | 9.04 Billion | - | 8.83 Billion | 8.36 Billion | 8.51 Billion |
| Earnings Before Tax Margin | 0.26 | 0.25 | 0.24 | 0.25 | 0.23 | 0.25 |
KROS
RKNEF
MMTIF
NONOF
UVSE
0II3